NWBO

Northwest Biotherapeutics, Inc. Common stock
NWBO

Overview Fund Activity
Delisted

NWBO was delisted on the 16th of December, 2016.

Back to rankings

8 hedge funds and large institutions have $160K invested in Northwest Biotherapeutics, Inc. Common stock in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.

Holders
8
Holders Change
-3
Holders Change %
-27.27%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
MSAM
1
Moloney Securities Asset Management
Missouri
$114K

Top Sellers

1
SL
1
Sentinus LLC
Illinois
$0
Name Market Value Shares Shares
Change 		Shares
Change %
MSAM
1
Moloney Securities Asset Management
Missouri
$114K 500,120 +11,600 +2%
VWA
2
VSM Wealth Advisory
Maryland
$15K 65,574 – –
OCG
3
Opus Capital Group
Ohio
$14K 60,150 – –
EFG
4
Ethos Financial Group
Pennsylvania
$6.51K 23,700 – –
WJWM
5
Williams Jones Wealth Management
New York
$6.17K 27,000 – –
KA
6
KLCM Advisors
Wisconsin
$2.28K 10,000 – –
AMG
7
Advisors Management Group
Wisconsin
$2K 10,270 – –
SL
8
Sentinus LLC
Illinois
– – -12,925 Closed
CMP
9
Coston McIsaac & Partners
Maine
– – -1,000 Closed
HFS
10
Hantz Financial Services
Michigan
$0 250 – –